Cel
Second-generation antipsychotics are increasingly being prescribed to children and adolescents. Their use, however, is mostly off-label, and adequate and sufficient data about efficacy and particular safety are lacking. This proposal focuses on two indications, the use of risperidone in children and adolescents with conduct disorder who are not mentally retarded, and the use of risperidone in adolescents with schizophrenia. The objectives are to 1) perform a series of clinical studies that will provide sufficient information for a Paediatric Use Marketing Authorisation to be obtained for these indications; 2) address scientific questions about the moderating and/or mediating factors of the efficacy and safety of risperidone in children and adolescents, and 3) disseminate the knowledge acquired by the proposed studies to medical and mental health professionals, to patients and their families and society in general.
Dziedzina nauki
Temat(-y)
Zaproszenie do składania wniosków
FP7-HEALTH-2009-single-stage
Zobacz inne projekty w ramach tego zaproszenia
System finansowania
CP-FP - Small or medium-scale focused research projectKoordynator
6525 XZ Nijmegen
Niderlandy
Zobacz na mapie
Uczestnicy (20)
9713 GZ Groningen
Zobacz na mapie
68159 Mannheim
Zobacz na mapie
WC1E 6BT London
Zobacz na mapie
DD1 4HN Dundee
Zobacz na mapie
WC1N 1AX LONDON
Zobacz na mapie
75012 Paris
Zobacz na mapie
28046 MADRID
Zobacz na mapie
08036 Barcelona
Zobacz na mapie
09124 Cagliari
Zobacz na mapie
3000 Leuven
Zobacz na mapie
56118 Pisa
Zobacz na mapie
00165 Roma
Zobacz na mapie
75654 Paris
Zobacz na mapie
89081 Ulm
Zobacz na mapie
LL139UF WREXHAM
Zobacz na mapie
28037 MADRID
Zobacz na mapie
82140 Olching
Zobacz na mapie
5611 GZ Eindhoven
Zobacz na mapie
KT11 3BN STOKE D ABERNON
Zobacz na mapie
00197 Rome
Zobacz na mapie